HBK Investments’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,905	Closed	-$1.77M	–	405
2021 Q2	$1.77M	Buy	10,905 +1,990	+22%	+$322K	0.01%	335
2021 Q1	$1.09M	Buy	+8,915	New	+$1.09M	﹤0.01%	379